ANTIDEPRESSANT ADHERENCE ACROSS DIVERSE POPULATIONS AND HEALTHCARE SETTINGS
- PMID: 27320786
- PMCID: PMC5618693
- DOI: 10.1002/da.22532
ANTIDEPRESSANT ADHERENCE ACROSS DIVERSE POPULATIONS AND HEALTHCARE SETTINGS
Abstract
Background: Early adherence is key to successful depression treatment, but nearly 60% of patients discontinue antidepressants within 3 months. Our study aimed to determine factors associated with poor early adherence to antidepressants in a large diverse sample of patients.
Methods: Six Mental Health Research Network healthcare systems contributed data for adults with depression and a new antidepressant start, defined by a washout period of at least 270 days, between January 1, 2010 and December 31, 2012. Pharmacy fill and self-reported race/ethnicity data were obtained from the electronic medical record. Patients had early adherence if they had a second antidepressant fill within 180 days of the first. We used logistic regression to investigate the relationship between early adherence and patient characteristics.
Results: A total of 177,469 adult patients had 184,967 new episodes of depression with a filled antidepressant prescription. Patients refilled their antidepressants within 180 days in 71% of episodes. Race/ethnicity was a strong predictor of early adherence, with patients from racial/ethnic minorities other than Native Americans/Alaskan Natives less likely (adjusted odd ratios 0.50-0.59) to refill their antidepressants than non-Hispanic whites. Age, neighborhood education, comorbidity burden, provider type and engagement in psychotherapy were also associated with adherence. Other apparent predictors of early adherence, including neighborhood income, gender, and prior mental health hospitalizations, were no longer significant in the fully adjusted model.
Conclusions: Race/ethnicity was a robust predictor of early antidepressant adherence, with minority groups other than Native Americans/Alaskan Natives less likely to be adherent. Further research is needed to determine whether early nonadherence in specific minority populations is intentional, due to side effects or patient preference, or unintentional and appropriate for targeted interventions to improve adherence.
Keywords: antidepressants; medication adherence; patient adherence.
© 2016 Wiley Periodicals, Inc.
Similar articles
-
Does Patient Adherence to Antidepressant Medication Actually Vary Between Physicians?J Clin Psychiatry. 2018 May/Jun;79(3):16m11324. doi: 10.4088/JCP.16m11324. J Clin Psychiatry. 2018. PMID: 29068611 Free PMC article.
-
Antidepressant prescriptions and adherence in primary care in India: Insights from a cluster randomized control trial.PLoS One. 2021 Mar 19;16(3):e0248641. doi: 10.1371/journal.pone.0248641. eCollection 2021. PLoS One. 2021. PMID: 33739982 Free PMC article. Clinical Trial.
-
Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.CNS Drugs. 2008;22(11):963-73. doi: 10.2165/00023210-200822110-00005. CNS Drugs. 2008. PMID: 18840035
-
A systematic review of measures of medication adherence in consumers with unipolar depression.Res Social Adm Pharm. 2019 Jan;15(1):3-22. doi: 10.1016/j.sapharm.2018.02.008. Epub 2018 Feb 21. Res Social Adm Pharm. 2019. PMID: 29526664
-
Using the Electronic Medical Record to Examine Racial and Ethnic Differences in Depression Diagnosis and Treatment in a Primary Care Population.Prim Health Care. 2012 Jan 4;1:1000106. doi: 10.4172/2167-1079.1000106. Prim Health Care. 2012. PMID: 24524015 Free PMC article. Review.
Cited by
-
KETO-MOOD: Ketogenic Diet for Microbiome Optimization and Overcoming Depression - A Protocol for a Randomized Controlled Trial.Neuroimmunomodulation. 2025;32(1):36-48. doi: 10.1159/000542979. Epub 2024 Dec 19. Neuroimmunomodulation. 2025. PMID: 39701054 Free PMC article.
-
A scoping review of the effects of mushroom and fungus extracts in rodent models of depression and tests of antidepressant activity.Front Pharmacol. 2024 Jun 3;15:1387158. doi: 10.3389/fphar.2024.1387158. eCollection 2024. Front Pharmacol. 2024. PMID: 38887548 Free PMC article.
-
Gut-Brain Axis in Mood Disorders: A Narrative Review of Neurobiological Insights and Probiotic Interventions.Biomedicines. 2025 Jul 26;13(8):1831. doi: 10.3390/biomedicines13081831. Biomedicines. 2025. PMID: 40868087 Free PMC article. Review.
-
Efficacy of the Integrative Acupuncture and Moxibustion Treatment in Patients With Major Depressive Disorder: The Study Protocol for a Multicenter, Single-Blinded, Randomized Trial in China.Front Med (Lausanne). 2022 May 30;9:761419. doi: 10.3389/fmed.2022.761419. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35707522 Free PMC article.
-
The impact of race and ethnicity on rates of return to psychotherapy for depression.Depress Anxiety. 2017 Dec;34(12):1157-1163. doi: 10.1002/da.22696. Epub 2017 Nov 2. Depress Anxiety. 2017. PMID: 29095538 Free PMC article.
References
-
- Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA. 2003;289(23):3095–3105. - PubMed
-
- Geddes JR, Carney SM, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet. 2003;361(9358):653–661. - PubMed
-
- Gartlehner G, Hansen RA, Thieda P, et al. Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression. Rockville (MD): 2007. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical